Tratamiento farmacológico y deterioro de la función pulmonar en pacientes con diabetes de tipo 2: un estudio de corte transversal

Vargas, Henry A; Rondón, Martín; Dennis, Rodolfo.
Biomédica (Bogotá) ; 36(2): 276-284, jun. 2016. tab
Artigo em Espanhol | LILACS | ID: lil-791117

Documentos relacionados

  1. Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes.
  2. Pharmacological treatment and impairment of pulmonary function in patients with type 2 diabetes: a cross-sectional study.
  3. Effect of eugenol on lipid profile, oxidative stress, sex hormone, liver injury, ovarian failure, and expression of COX-2 and PPAR-α genes in a rat model of diabetes.
  4. Propensity Score Matching to Determine the Impact of Metformin on All-Cause Mortality in Older Veterans with Diabetes Mellitus.
  5. Influence of Early Postoperative Basal Insulin Treatment and Post-Transplant Diabetes Mellitus Risk on Health-Related Quality of Life in Kidney Transplant Recipients-An Analysis of Data From a Randomized Controlled Trial.
  6. Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study.
  7. Assessment of insulin adherence in diabetic outpatients: An observational study.
  8. Assessment of Lung Functions by Spirometry in Diabetics with no Respiratory Complaints.
  9. Patient and Prehospital Predictors of Hospital Admission for Patients With and Without Histories of Diabetes Treated by Paramedics for Hypoglycemia: A Health Record Review Study.
  10. Descarte correto de resíduo doméstico de pessoas em uso de insulina: tecnologia para educação ao paciente